Recon: Eli Lilly wins FDA nod for obesity therapy Zepbound; Fully synthetic genome nears completion
ReconJason Scott
Advanced therapies/cell and gene therapyAfricaAPIsAsiaBiologics/ biosimilars/ vaccinesBiotechnologyCanadaCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIEuropeGenericsGlobalLatin America/CaribbeanMedical DevicesMiddle EastNorth AmericaNutritional/Natural HealthOceaniaOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyUnited States